Showing results 6 to 9 of 9
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2017 | |||
Targeting Serine Peptidase Inhibitor, Kazal Type 1 (SPINK1) as a Potential Treatment for Hepatocellular Carcinoma Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2011 | 2011 | ||
The role of serine peptidase inhibitor, Kazal type I (SPINK1) in hepatocellular carcinoma Proceeding/Conference:Cancer Omics | 2010 | ||
Tumorigenic properties of serine peptidase inhibitor, Kazal type 1 (SPINK1) in hepatocellular carcinoma Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2011 | 2011 |